Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
Glanbia Nutritionals is seeking to propel its growth in China via general lifestyle nutrition, in addition to its sports nutrition stronghold, with a key focus on creating new concepts in tandem with its customers.
Indian entrepreneur incubation hub Biovalley Incubation Council has announced the five start-up products it will fund in the nutrition and biotechnology sectors, among them a high-protein chilli and a novel probiotic technology that speeds up fermentation.
UK firm OptiBiotix is looking to increase its APAC presence, with Food Standards and Safety Authority of India (FSSAI) approval the latest development in its expansion plans withits weight management product, SlimBiome.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
Tmall reveals China's top seven F&B trends, a Singapore-based sports nutrition retailer tells us about its plans to shake up the industry, and we bring you the latest on our upcoming Healthy Ageing APAC Summit and NutraIngredients-Asia Awards.
NutraIngredients-Asia's annual awards are open for entries, and here are the final six judges who will assess the submissions from the best and brightest manufacturers, suppliers and researchers in the region.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.